NPG Neurologie, Psychiatrie, Gériatrie/NPG · Nov 2026

Vaccination as a strategy for cardiovascular disease prevention in older adults

By Ecarnot F

Acute respiratory infection is an established trigger of cardiovascular events in older adults, and there is accumulating evidence showing that acute infection (notably influenza, SARS-CoV-2, pneumococcal disease, respiratory syncytial virus (RSV), and herpes zoster) are associated with an increased risk of acute cardiovascular events, especially decompensated heart failure. Vaccination can prevent infection, and may consequently also reduce the attendant risk of cardiovascular events. In this narrative review, we appraise the evidence for cardiovascular protection in older adults through vaccination, focusing particularly on influenza, SARS-CoV-2, pneumococcal disease, respiratory syncytial virus (RSV), and herpes zoster. We summarize international recommendations regarding vaccination of older adults, and focus in particular on recent changes in French vaccine policy. Finally, we cite some remaining gaps in the evidence for cardiovascular protection of older adults through immunization.

doi.org/10.1016/j.npg.2026.10.009Open accessInterventions

AgingResearch.News